Verstandig Grant 4
4 · NexImmune, Inc. · Filed Feb 19, 2021
Insider Transaction Report
Form 4
NexImmune, Inc.NEXI
Verstandig Grant
Director
Transactions
- Conversion
Common Stock
2021-02-17+539,895→ 539,895 total - Purchase
Common Stock
2021-02-17$17.00/sh+175,000$2,975,000→ 714,895 total - Conversion
Convertible Promissory Note
2021-02-17→ 0 total→ Common Stock (539,895 underlying)
Footnotes (3)
- [F1]On February 17, 2021 (the "Closing"), the convertible promissory notes (the "Notes") became automatically convertible into shares of the Issuer's common stock. At the Closing, the principal amount of the Notes, plus accrued but unpaid interest thereon through February 17, 2021, converted into shares of the Issuer's common stock by dividing the principal and accrued but unpaid interest under such Note by the price per share obtained by dividing $125,000,000 by the Company's fully-diluted capitalization immediately prior to the IPO, assuming exercise or conversion of all convertible securities of the Company but excluding any shares issuable upon conversion of the Notes.
- [F2]Reflects shares purchased in the Issuer's initial public offering.
- [F3]Not applicable.